55. Statement on management strategy for patients with autosomal dominant polycystic kidney disease(ADPKD), which is incorrect:
(A) Dietary salt restriction may be beneficial in the management of ADPKD。
(B) Angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB) are thefirst-line antihypertensive drugs in ADPKD。
(C) Nonsteroidal anti-inflammatory drugs (NSAIDs) is more effective and safe than acetaminophen ortramadol for cystic pain relief in ADPKD patients。
(D) Oral tolvaptan can slow the increase in total kidney volume and the decline in kidney function ofADPKD patients。
(E) ADPKD patients can be a recipient for renal transplantation。